Swiss National Bank
MIRM icon

Swiss National Bank’s Mirum Pharmaceuticals MIRM Stock Holding History

Swiss National Bank’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.93M Buy
84,800
+10,500
+14% +$1.05M 0.01% 1024
2026
Q1 		$6.86M Hold
74,300
– – ﹤0.01% 1159
2025
Q4 		$5.87M Buy
74,300
+2,300
+3% +$165K ﹤0.01% 1262
2025
Q3 		$5.28M Buy
72,000
+1,800
+3% +$114K ﹤0.01% 1301
2025
Q2 		$3.57M Buy
70,200
+400
+0.6% +$17.8K ﹤0.01% 1465
2025
Q1 		$3.14M Sell
69,800
-500
-0.7% -$23.6K ﹤0.01% 1517
2024
Q4 		$2.91M Buy
70,300
+1,300
+2% +$54.2K ﹤0.01% 1642
2024
Q3 		$2.69M Buy
69,000
+4,200
+6% +$168K ﹤0.01% 1689
2024
Q2 		$2.22M Buy
64,800
+5,500
+9% +$144K ﹤0.01% 1752
2024
Q1 		$1.49M Hold
59,300
– – ﹤0.01% 1998
2023
Q4 		$1.75M Buy
59,300
+4,900
+9% +$148K ﹤0.01% 1925
2023
Q3 		$1.72M Buy
54,400
+700
+1% +$19.2K ﹤0.01% 1933
2023
Q2 		$1.39M Buy
53,700
+9,900
+23% +$263K ﹤0.01% 2127
2023
Q1 		$1.05M Sell
43,800
-4,300
-9% -$98K ﹤0.01% 2224
2022
Q4 		$938K Buy
48,100
+1,100
+2% +$21.7K ﹤0.01% 2379
2022
Q3 		$987K Buy
47,000
+9,600
+26% +$231K ﹤0.01% 2349
2022
Q2 		$728K Buy
+37,400
New +$882K ﹤0.01% 2509

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Swiss National Bank's MIRM Position: Q2 2026 in Review

Swiss National Bank increased its Mirum Pharmaceuticals (MIRM) stake by 14% in Q2 2026, buying an estimated $1.05M and bringing the position to 84,800 shares worth $9.93M. The position accounts for 0.01% of the portfolio, ranked #1024.

Swiss National Bank first reported a position in MIRM in Q2 2022 and has held it in 17 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Swiss National Bank held 84,800 shares of Mirum Pharmaceuticals worth $9.93M as of Q2 2026.
  • Swiss National Bank bought 10,500 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.05M.
  • Mirum Pharmaceuticals made up 0.01% of Swiss National Bank's portfolio in Q2 2026, its #1024 holding.
  • Swiss National Bank first reported a position in Mirum Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.